Overview

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99

Status:
No longer available
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
An expanded access trial of belimumab for named patients who participated in LBRA99.
Details
Lead Sponsor:
Human Genome Sciences Inc., a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Antibodies
Belimumab